Tumour cell surface antigen targeted therapies in B-cell lymphomas: Beyond rituximab
Author:
Funder
Novartis
Pharmacyclics
Merck KGaA
Bayer
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference172 articles.
1. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project;Armitage;J Clin Oncol,1998
2. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues;Swerdlow,2008
3. Management of indolent lymphoma: where are we now and where are we going;Lunning;Blood Rev,2012
4. Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells;Shan;Cancer Immunol Immunother,2000
5. Antibody therapy of cancer;Scott;Nat Rev Cancer,2012
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Conditional activation of an anti-IgM antibody-drug conjugate for precise B cell lymphoma targeting;Frontiers in Immunology;2023-09-28
2. Diagnostic value of serum tumor-associated autoantibodies in esophageal cancer;Biomarkers in Medicine;2021-10
3. Therapeutic roles of antibody drug conjugates (ADCs) in relapsed/refractory lymphomas;Hematology/Oncology and Stem Cell Therapy;2021-07
4. Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark Antibodies;Frontiers in Immunology;2020-11-26
5. Development of Traceable Rituximab-Modified PEO-Polyester Micelles by Postinsertion of PEG-phospholipids for Targeting of B-cell Lymphoma;ACS Omega;2019-11-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3